Impulse Dynamics and MetaCure Sign Asia-Pacific distribution Agreements with Vitality Devices

Australia (PRWEB) February 21, 2012

Under this agreement Vitality will distribute Impulse Dynamics’ OPTIMIZER Method for treating Chronic Heart Failure (CHF) and MetaCure’s DIAMOND Method for treating Sort 2 Diabetes and related metabolic illnesses. Distribution of both medical devices will be in Australia, Singapore, Taiwan, South Korea, the Philippines, New Zealand, Indonesia, Malaysia, Thailand, Vietnam, Cambodia, Laos and the United Arab Emirates.

Vitality was established by Australian biotechnology entrepreneurs Dr. Greg Collier and Dr. James Campbell, who previously served as the executive management team of the drug development business ChemGenex Pharmaceuticals from 2002, guiding its growth, clinical development and ultimate sale to Cephalon Inc. in 2011. Vitality will specialize in commercializing medical technologies in the Asia Pacific region it will concentrate on the Impulse Dynamics and MetaCure implants as the cornerstone of its commercial platform, adding further medical devices more than time.

“We view our partnership agreement with Vitality as a strategic asset,” said Impulse Dynamics and MetaCure CEO, Dr. Irit Yaniv. “With the growing incidence of Chronic Heart Failure and Metabolic Disease all through the Asia Pacific region, we view these markets as a main commercial target and source of growth for our companies”.

Impulse Dynamic’s Optimizer III and Metacure’s Diamond Technique represent technological advancement in device based illness treatment. The Optimizer III implant makes use of Cardiac Contractility Modulation (CCM) treatment to boost exercise tolerance and good quality of life in CHF patients. The DIAMOND Method is an implantable electrical stimulator for improving blood glucose levels and metabolic parameters in patients suffering from diabesity.

“We are excited about the chance to introduce novel, state of the art medical technologies such as the OPTIMIZER III and DIAMOND Program to patients in the region” stated Dr. Greg Collier, Managing Director of Vitality. “We believe that these technologies will enhance readily available treatment and good quality of care for heart failure and metabolic patients all through these territories”.

About Impulse Dynamics

Impulse Dynamics is a medical device organization devoted to providing innovative solutions for treatment of Chronic Heart Failure. The Optimizer III with Cardiac Contractility Modulation (CCM) therapy is CE marked and is obtainable in pick excellence centers across Europe and Asia.

About MetaCure

MetaCure is a medical device company devoted to establishing innovative minimally invasive Interventional Diabetology solutions for Kind 2 Diabetes and its metabolic comorbidities. The Company’s leading item, The DIAMOND Program has been shown to significantly enhance glycemic and metabolic manage while preserving a clean safety profile. The DIAMOND System is CE approved since 2007 and is commercially readily available in chosen excellence centers in Europe.

###

©Copyright 1997-

, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.